PURPOSE: To determine the association between complement factor H (CFH) polymorphism T1277C (tyrosine-402 --> histidine-402) and phenotypic variations of age-related macular degeneration (AMD). DESIGN: Cross-sectional observational study. PARTICIPANTS: Subjects with dry or wet AMD and a control population consisting of age-matched non-AMD subjects from 2 clinical facilities examined during the period January 1, 1999 through December 31, 2002. METHODS: Total DNA isolated from the leukocytes of 66 AMD subjects and 58 age-matched control subjects was studied. The CFH gene was amplified by polymerase chain reaction and analyzed by Nla III restriction fragment length analysis. MAIN OUTCOME MEASURES: Incidence of CHF polymorphism with the occurrence of AMD. RESULTS: Among the AMD patients, 15 had dry and 51 had wet AMD. For the CFH gene, the T1277C variant showed the genotype distribution as CC, TC, and TT. There was a strong association between homozygous C and AMD compared with the control population (odds ratio [OR] = 3.4; 95% confidence interval [CI], 1.32-8.74; P = 0.0053). Furthermore, dry AMD had a stronger association (OR, 8.32; 95% CI, 2.30-30.11; P = 0.001) than wet AMD (OR, 2.49; 95% CI, 0.90-6.84; P = 0.039) compared with the control population. Homozygous T was more prevalent in the control subjects compared with AMD patients (OR, 5; 95% CI, 2.18-11.43; P = 0.00005). CONCLUSIONS: Complement factor H polymorphism T1277C (tyrosine-402 --> histidine-402) is strongly associated with both dry and wet AMD and points to a possible role for inflammation in the pathogenesis of AMD.
PURPOSE: To determine the association between complement factor H (CFH) polymorphism T1277C (tyrosine-402 --> histidine-402) and phenotypic variations of age-related macular degeneration (AMD). DESIGN: Cross-sectional observational study. PARTICIPANTS: Subjects with dry or wet AMD and a control population consisting of age-matched non-AMD subjects from 2 clinical facilities examined during the period January 1, 1999 through December 31, 2002. METHODS: Total DNA isolated from the leukocytes of 66 AMD subjects and 58 age-matched control subjects was studied. The CFH gene was amplified by polymerase chain reaction and analyzed by Nla III restriction fragment length analysis. MAIN OUTCOME MEASURES: Incidence of CHF polymorphism with the occurrence of AMD. RESULTS: Among the AMDpatients, 15 had dry and 51 had wet AMD. For the CFH gene, the T1277C variant showed the genotype distribution as CC, TC, and TT. There was a strong association between homozygous C and AMD compared with the control population (odds ratio [OR] = 3.4; 95% confidence interval [CI], 1.32-8.74; P = 0.0053). Furthermore, dry AMD had a stronger association (OR, 8.32; 95% CI, 2.30-30.11; P = 0.001) than wet AMD (OR, 2.49; 95% CI, 0.90-6.84; P = 0.039) compared with the control population. Homozygous T was more prevalent in the control subjects compared with AMDpatients (OR, 5; 95% CI, 2.18-11.43; P = 0.00005). CONCLUSIONS:Complement factor H polymorphism T1277C (tyrosine-402 --> histidine-402) is strongly associated with both dry and wet AMD and points to a possible role for inflammation in the pathogenesis of AMD.
Authors: Gillian Hamilton; Petra Proitsi; Julie Williams; Michael O'Donovan; Michael Owen; John Powell; Simon Lovestone Journal: Neuromolecular Med Date: 2007-09-22 Impact factor: 3.843
Authors: Bareng A S Nonyane; Dorothea Nitsch; John C Whittaker; Reecha Sofat; Liam Smeeth; Usha Chakravarthy; Astrid E Fletcher Journal: Invest Ophthalmol Vis Sci Date: 2009-12-30 Impact factor: 4.799
Authors: M Cristina Kenney; Marilyn Chwa; Shari R Atilano; Janelle M Pavlis; Payam Falatoonzadeh; Claudio Ramirez; Deepika Malik; Tiffany Hsu; Grace Woo; Kyaw Soe; Anthony B Nesburn; David S Boyer; Baruch D Kuppermann; S Michal Jazwinski; Michael V Miceli; Douglas C Wallace; Nitin Udar Journal: PLoS One Date: 2013-01-24 Impact factor: 3.240
Authors: M Cristina Kenney; Dieter Hertzog; Garrick Chak; Shari R Atilano; Nikan Khatibi; Kyaw Soe; Andrew Nobe; Elizabeth Yang; Marilyn Chwa; Feilin Zhu; Masood Memarzadeh; Jacqueline King; Jonathan Langberg; Kent Small; Anthony B Nesburn; David S Boyer; Nitin Udar Journal: BMC Med Genet Date: 2013-01-09 Impact factor: 2.103
Authors: Sanna P Seitsonen; Päivi Onkamo; Gang Peng; Momiao Xiong; Petri V Tommila; Päivi H Ranta; Juha M Holopainen; Jukka A Moilanen; Tapani Palosaari; Kai Kaarniranta; Seppo Meri; Ilkka R Immonen; Irma E Järvelä Journal: PLoS One Date: 2008-12-02 Impact factor: 3.240
Authors: Johanna Jakobsdottir; Yvette P Conley; Daniel E Weeks; Robert E Ferrell; Michael B Gorin Journal: PLoS One Date: 2008-05-21 Impact factor: 3.240